Phibro Animal Health Corporation $PAHC Stock Sold by Hennessy Advisors Inc.

Hennessy Advisors Inc. lessened its stake in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) by 8.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 202,000 shares of the company’s stock after selling 19,700 shares during the quarter. Hennessy Advisors Inc. owned 0.50% of Phibro Animal Health worth $7,219,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. KBC Group NV purchased a new stake in shares of Phibro Animal Health in the 1st quarter valued at approximately $29,000. Sterling Capital Management LLC boosted its position in shares of Phibro Animal Health by 864.9% during the 3rd quarter. Sterling Capital Management LLC now owns 714 shares of the company’s stock worth $26,000 after purchasing an additional 640 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Phibro Animal Health during the 3rd quarter worth approximately $39,000. Inspire Investing LLC purchased a new position in shares of Phibro Animal Health during the 1st quarter worth approximately $158,000. Finally, China Universal Asset Management Co. Ltd. increased its holdings in Phibro Animal Health by 14.9% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,851 shares of the company’s stock valued at $137,000 after purchasing an additional 498 shares during the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Price Performance

PAHC stock opened at $38.88 on Monday. Phibro Animal Health Corporation has a fifty-two week low of $28.25 and a fifty-two week high of $60.08. The company’s 50 day moving average price is $36.99 and its 200 day moving average price is $41.12. The company has a debt-to-equity ratio of 1.84, a quick ratio of 1.27 and a current ratio of 2.96. The firm has a market capitalization of $1.58 billion, a price-to-earnings ratio of 15.93 and a beta of 0.42.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Wednesday, August 26th. The company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.71 by $0.14. Phibro Animal Health had a return on equity of 37.86% and a net margin of 6.57%. The business had revenue of $396.75 million for the quarter, compared to the consensus estimate of $381.18 million. Phibro Animal Health has set its FY 2027 guidance at 3.410-3.590 EPS. On average, equities research analysts anticipate that Phibro Animal Health Corporation will post 3.49 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts have issued reports on the company. Zacks Research raised Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research report on Friday, September 18th. Weiss Ratings restated a “hold (c+)” rating on shares of Phibro Animal Health in a research report on Friday, September 11th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $47.67.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation develops, manufactures and sells products designed to support the health, nutrition and productivity of food-producing animals. Its offerings include animal health products, vaccines, medicated feed additives, nutritional specialties and performance products used in livestock, poultry and aquaculture.

The company’s products are intended to help prevent and manage disease, improve animal well-being and support efficient food production. Phibro serves producers, veterinarians, feed manufacturers and distributors through a portfolio that includes pharmaceuticals, vaccines, mineral and nutritional supplements, and other feed and water solutions.

Phibro Animal Health markets its products internationally across a broad range of geographic regions, including North America, Latin America, Europe, Asia-Pacific and other global markets.